MUMBAI, India, May 1 -- Intellectual Property India has published a patent application (202611024924 A) filed by Swami Vivekanand Subharti University, Meerut, Uttar Pradesh, on March 3, for 'a method, a computational system and a platform for artificial intelligence-assisted drug repurposing and optimization for central nervous system disorders.'
Inventor(s) include Akansha Singh; and Priyadarshini Soni.
The application for the patent was published on May 1, under issue no. 18/2026.
According to the abstract released by the Intellectual Property India: "The present invention relates to an artificial intelligence-assisted computational system and method for drug repurposing in central nervous system (CNS) disorders. The system integrates multi-modal pharmacological, chemical, genomic, and toxicological datasets to identify and prioritize repurposable therapeutic agents. An artificial intelligence and machine learning (AI/ML) engine extracts molecular descriptors and predicts drug-target interaction probabilities and therapeutic efficacy. A blood-brain barrier (BBB) simulation module computes dynamic permeability indices based on physicochemical parameters, while a neurotoxicity assessment module evaluates neural safety risks. A multi-objective optimization engine simultaneously balances efficacy, BBB penetration, and neurotoxicity constraints to generate a composite CNS suitability score for ranking candidate drugs. The system may further recommend structural or formulation modifications to enhance CNS compatibility."
Disclaimer: Curated by HT Syndication.
